Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
QHSLab ( (USAQ) ) just unveiled an announcement.
On January 26, 2026, QHSLab reported preliminary unaudited financial results for 2025 showing revenue rose just over 25% to $2.68 million and gross profit increased more than 32% to $1.80 million, with gross margins improving from about 64% to roughly 67% despite operating with a lean cost structure. During the fourth quarter of 2025, the company executed a major balance-sheet cleanup by reducing outstanding convertible debt and accrued interest from approximately $2.0 million to about $20,000, which is expected to cut annual interest expense by more than $200,000 and free up cash for product development, sales, and platform expansion; management also highlighted early reimbursement activity from its Q-Cog cognitive and behavioral screening solution and growing momentum in its Integrated Service Program client base as positioning QHSLab for continued progress in 2026, with final audited 2025 results to follow in its forthcoming annual report.
The most recent analyst rating on (USAQ) stock is a Hold with a $0.94 price target. To see the full list of analyst forecasts on QHSLab stock, see the USAQ Stock Forecast page.
Spark’s Take on USAQ Stock
According to Spark, TipRanks’ AI Analyst, USAQ is a Neutral.
Score is held back primarily by financial risk—ongoing net losses and negative equity—despite improved revenue, solid gross margins, and positive free cash flow. Technicals are a key offset with strong upward trend and positive momentum. Corporate actions to deleverage and strengthen governance are supportive, while valuation is unattractive/unclear due to negative earnings and no dividend.
To see Spark’s full report on USAQ stock, click here.
More about QHSLab
QHSLab, Inc. (OTCQB: USAQ) is a digital health infrastructure company that provides preventive screening, assessment, and workflow solutions for primary care practices. Its platform supports care delivered outside the exam room—such as screening, monitoring, education, and follow-up—enabling this activity to be scalable, documented, and reimbursable across multiple underdiagnosed conditions, with a particular focus on primary-care reimbursement workflows.
Average Trading Volume: 17,753
Technical Sentiment Signal: Buy
Current Market Cap: $10.38M
See more insights into USAQ stock on TipRanks’ Stock Analysis page.